Anti-Arthritic Activity of Phosphinegold(I) Thiolates in Rats
Author Information
Author(s): Michael W. Whitehouse, Peter D. Cookson, George Siasios, Edward R.T. Tiekink
Primary Institution: The University of Queensland
Hypothesis
The study investigates the anti-arthritic activity of phosphinegold(I) thiolates derived from thionucleobases in a rat model.
Conclusion
Some phosphinegold(I) thiolates show significant anti-arthritic potency and reduced toxicity compared to existing treatments.
Supporting Evidence
- Phosphinegold(I) thiolates derived from thionucleobases showed comparable or greater potency than Myocrisin and Auranofin.
- The most active complex was [Et3PAu(6-MP)], which had the least toxicity.
- Substitutions in the thiolate ligands affected both potency and toxicity.
- Some complexes were less toxic than existing gold-based treatments.
Takeaway
Scientists tested new gold-based drugs on sick rats to see if they could help with arthritis, and some worked better than the old medicines.
Methodology
The study involved screening various phosphinegold(I) thiolates for anti-arthritic activity in Dark Agouti rats using a mycobacterial adjuvant to induce arthritis.
Limitations
The study did not conduct full toxicity screens on all tested complexes.
Participant Demographics
Dark Agouti rats, a gold-sensitive strain.
Want to read the original?
Access the complete publication on the publisher's website